Gaurav Shah insider trades

Open-market stock purchases and sales by Gaurav Shah, CEO at Rocket Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 29, 2018.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -66%.

Recent trades

DateStockTradeValue
May 21, 2026RCKT Rocket Pharmaceuticals, IncSold$172K
May 21, 2026RCKT Rocket Pharmaceuticals, IncBought (not open market)$129K
May 19, 2026RCKT Rocket Pharmaceuticals, IncSold$7.3K
May 13, 2026RCKT Rocket Pharmaceuticals, IncSold$9.8K
Feb 18, 2026RCKT Rocket Pharmaceuticals, IncSold$20K
Feb 13, 2026RCKT Rocket Pharmaceuticals, IncSold$40.7K
Feb 11, 2026RCKT Rocket Pharmaceuticals, IncBought (not open market)—
Feb 11, 2026RCKT Rocket Pharmaceuticals, IncBought (not open market)—
Nov 18, 2025RCKT Rocket Pharmaceuticals, IncSold$18.7K

Companies traded

  • RCKT Rocket Pharmaceuticals, Inc: 2 buys, 16 sales, last May 21, 2026
  • TALS Talaris Therapeutics, Inc: other filings, last Jun 13, 2023

Get free alerts when Gaurav Shah files a new trade →